No Data
No Data
STARGLORY HLDGS (08213.HK) plans to issue a total of 34.2857 million shares at a discount of approximately 12.50%, raising about 11.7 million Hong Kong dollars.
On December 18, Gelonghui reported that STARGLORY HLDGS (08213.HK) announced that on December 18, 2024, the company entered into subscription agreements with each subscriber, according to which each subscriber has conditionally agreed to subscribe, and the company has conditionally agreed to issue a total of 34,285,713 new shares at a subscription price of HKD 0.35 per share. The subscription price of HKD 0.35 per share represents a discount of approximately 12.50% compared to the closing price of HKD 0.40 per share reported on the Hong Kong Exchange at the date of the subscription agreement; the total of 34,285,713 shares to be subscribed represents a percentage of the company's existing shares as of the date of this announcement.
Express News | StarGlory Holdings - to Issue Aggregate 34.3 Mln New Shares at HK$0.35 per Subscription Share
STARGLORY HLDGS: INTERIM REPORT FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2024
STARGLORY HLDGS: INTERIM RESULTS ANNOUNCEMENTFOR THE SIX MONTHS ENDED 30 SEPTEMBER 2024
Starglory hldgs (08213.HK) profit warning: expects a mid-term net loss of 9.1 million Hong Kong dollars to 12.3 million Hong Kong dollars.
Starglory hldgs (08213.HK) announced on November 21 that the Group expects to record a company's attributable loss of 9.1 million to 12.3 million Hong Kong dollars for the six-month reporting period ending on September 30, 2024, compared to a company's attributable loss of approximately 5.9 million Hong Kong dollars in the same period last year. The increase in loss is mainly due to a decrease in income from the sale of subsidiary companies of about 6.1 million Hong Kong dollars. As of the six months ended September 30, 2023, the Group sold one of its subsidiary companies to an independent third party and Huayin (Shenzhen) Bio-Technology Co., Ltd. ("Huayin Bio-Tech").
Express News | StarGlory Sees Loss Attributable HK$9.1 Mln to HK$12.3 Mln for Six Months